What's in Visirna Therapeutics HK Limited's pipeline?

Visirna Therapeutics HK Limited has 4 drugs in our index: 0 marketed, 0 filed, 2 in Phase 3, 1 in Phase 2, 1 in Phase 1.

Which companies overlap with Visirna Therapeutics HK Limited's portfolio?

Top competitors by shared drug class: Aclaris Therapeutics, Inc., Addpharma Inc., Appello Pharmaceuticals, Inc., Gedeon Richter Plc., Geropharm.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/visirna-therapeutics-hk-limited.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Visirna Therapeutics HK Limited — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Visirna Therapeutics HK Limited pipeline: 0 marketed, 0 filed, 2 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 1 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Placebon	Placebon	phase 3	Serotonin receptor antagonist	5-HT1A receptor	Psychiatry
VSA003	VSA003	phase 3

Therapeutic area mix

Psychiatry · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Aclaris Therapeutics, Inc. · 1 shared drug class
Addpharma Inc. · 1 shared drug class
Appello Pharmaceuticals, Inc. · 1 shared drug class
Gedeon Richter Plc. · 1 shared drug class
Geropharm · 1 shared drug class
H. Lundbeck A/S · 1 shared drug class
Infan Industria Quimica Farmaceutica Nacional · 1 shared drug class
Phytopharm Consulting Brazil · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Visirna Therapeutics HK Limited:

Cite this brief

Drug Landscape (2026). Visirna Therapeutics HK Limited — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/visirna-therapeutics-hk-limited. Accessed 2026-05-17.